Severe, intractable pain arising from upper abdominal malignancies, most notably pancreatic cancer, represents a significant clinical challenge. This type of visceral pain is often poorly responsive to systemic opioids and can be a source of profound suffering, dramatically impacting a patient’s quality of life. The celiac plexus block and its neurolytic variant are powerful interventional tools designed to interrupt the primary pain pathways from the upper abdominal viscera, offering potent analgesia, reducing opioid requirements, and improving function for patients with debilitating cancer-related pain.

Pathophysiology of Malignant Visceral Pain

The pain from cancers of the pancreas, stomach, liver, and gallbladder is multifactorial. It is driven by the infiltration and compression of retroperitoneal structures, perineural invasion by tumor cells, and obstruction of ducts. These processes activate and sensitize nociceptors that travel via the sympathetic nervous system to the celiac plexus, the main afferent hub for the upper abdominal organs. This results in a deep, gnawing, and often constant pain that radiates to the mid-back and is frequently exacerbated by eating or lying supine.

Anatomy of the Celiac Plexus

A precise understanding of the celiac plexus anatomy is critical for a safe and successful block.

• Location: The celiac plexus is a dense, web-like network of nerve fibers and ganglia situated in the retroperitoneum. It is located anterior to the abdominal aorta and diaphragmatic crura, typically at the level of the T12-L1 vertebral bodies, surrounding the origins of the celiac and superior mesenteric arteries.
• Innervation: It serves as the primary innervation for the foregut and midgut derivatives. This includes the distal esophagus, stomach, liver, gallbladder, pancreas, spleen, adrenal glands, kidneys, and the small intestine down to the splenic flexure of the colon.
• Afferent/Efferent Fibers: The plexus contains postganglionic sympathetic fibers, preganglionic parasympathetic fibers from the vagus nerve, and, most importantly for pain management, visceral afferent (sensory) fibers that travel with the sympathetic nerves. These sensory fibers are the target of the block.
• Contributing Nerves: The plexus is formed by contributions from the greater, lesser, and least splanchnic nerves (T5-T12), which carry the sympathetic and visceral afferent fibers.

Celiac Plexus Block: The Procedure

The procedure involves placing needles near the celiac plexus under image guidance to deliver medication.

• Indications: The primary indication is intractable pain from upper abdominal malignancies, especially pancreatic cancer. It can also be used for some chronic benign conditions like chronic pancreatitis, though neurolysis is generally avoided in non-malignant pain.
• Technique: The procedure is almost always performed using image guidance (fluoroscopy or CT). The most common approach is the posterior retrocrural approach, where two needles are advanced from a posterior entry point, passing just lateral to the vertebral body, until the tips are positioned in the retrocrural space on either side of the aorta at the T12-L1 level.
• Diagnostic Block vs. Neurolysis:
  • Diagnostic Block: A small volume of local anesthetic (e.g., bupivacaine) is injected. A successful block is defined by significant pain relief (typically >50-80%). This confirms that the patient’s pain is mediated by the celiac plexus and predicts a good response to neurolysis.
  • Neurolysis: Once a diagnostic block is confirmed, a neurolytic agent—most commonly dehydrated alcohol (50-100%) or phenol—is injected to destroy the plexus’s nerve fibers. This provides a long-lasting block, often for the remainder of the patient’s life.
• Splanchnic Nerve Block: An alternative is to target the splanchnic nerves before they reach the celiac plexus, as they course along the anterolateral aspect of the T11 and T12 vertebral bodies. This may reduce the risk of vascular injury and provides comparable analgesia.

Complications and Side Effects

While generally safe, the celiac plexus block has several potential complications and predictable side effects.

• Common, Expected Side Effects: Due to the intended blockade of sympathetic fibers, patients commonly experience:
  • Orthostatic Hypotension: The most common side effect. It is usually transient and managed with fluid hydration.
  • Increased Gastrointestinal Motility (Diarrhea): Caused by the unopposed parasympathetic (vagal) activity. This is also typically transient.
• Potential Complications:
  • Local Pain: Pain at the needle insertion site is common.
  • Bleeding/Hemorrhage: Due to the proximity of the aorta, vena cava, and other vessels.
  • Nerve Injury: Damage to somatic nerve roots can cause sensory or motor deficits.
  • Paraplegia: The most feared complication, though exceedingly rare. It is thought to result from injury to the artery of Adamkiewicz, a critical artery supplying the spinal cord.
  • Visceral or Kidney Injury: From errant needle placement.

Conclusion

The celiac plexus block is an invaluable procedure in the armamentarium of the interventional pain physician, particularly in the palliative care setting. For patients suffering from the relentless pain of upper abdominal cancer, this block can provide profound analgesia, significantly decrease opioid consumption and its associated side effects, and restore a measure of comfort and dignity. Proper patient selection, meticulous technique under image guidance, and a thorough understanding of the relevant anatomy are paramount to maximizing efficacy and ensuring patient safety.